CALD Australians face greater risk of medication errors, report urges new safeguards
A Pharmaceutical Society of Australia report finds people from culturally and linguistically diverse backgrounds are more likely to suffer medication-related harm and recommends interpreter use and home medicine reviews.
Research released by the Pharmaceutical Society of Australia shows that Australians from culturally and linguistically diverse (CALD) backgrounds experience a higher incidence of medication-related problems due to language hurdles, low health literacy and cultural practices. In 2022, 4.6 million one outlet users were overseas-born, half a million of whom reported limited English, and many were on six or more medicines. Pharmacist-turned-translator Evelyn Pe recounted cases ranging from inappropriate use of cancer drugs to incomplete antibiotic courses.
PSA president Mark Naunton called for clearer communication, citing preventable hospitalisations linked to medication errors. The society outlines five recommendations: broader interpreter use, more home medicine reviews, better data gathering, culturally appropriate information, and pharmacist cultural-awareness training. The federal Department of Health notes existing interpreter funding but acknowledges low awareness among CALD communities, while specialist Geraldine Moses supports the suggested measures.
Why it matters
Improving medication safety for CALD patients can reduce preventable hospital visits and save lives.
In this story
